共 9 条
[1]
[2]
[3]
Estimates of overdiagnosis of invasive breast cancer associated with screening mammography[J] Stephen Morrell;Alexandra Barratt;Les Irwig;Kirsten Howard;Corné Biesheuvel;Bruce Armstrong Cancer Causes & Control 2010,
[4]
Screening ultrasonography revealed 15% of mammographically occult breast cancers[J] Ken Uchida;Akinori Yamashita;Kazumi Kawase;Kentarou Kamiya Breast Cancer 2008,
[5]
Cost-Effectiveness Analysis of a Quality-Controlled Mammography Screening Program from the Swiss Statutory Health-Care Perspective: Quantitative Assessment of the Most Influential Factors[J] Kurt Neeser;Thomas Szucs;Jean-Luc Bulliard;Gaudenz Bachmann;Wendelin Schramm Value in Health 2007,
[6]
The cost-utility of magnetic resonance imaging for breast cancer in BRCA1 mutation carriers aged 30–49[J] Richard P. A. Norman;D. Gareth Evans;Douglas F. Easton;Kenneth C. Young The European Journal of Health Economics 2007,
[7]
Predictors of Sensitivity of Clinical Breast Examination (CBE)[J] Nina Oestreicher;Emily White;Constance D. Lehman;Margaret T. Mandelson;Peggy L. Porter;Stephen H. Taplin Breast Cancer Research and Treatment 2002,
[8]
Interpretation of cost-effectiveness analyses[J] Douglas K. Owens Journal of General Internal Medicine 1998,
[9]
Cost effectiveness of breast cancer screening with contrast-enhanced MRI in high-risk women Taneja C;Edelsberg J;Weycker Det al; J Am Coll Radiol 2009,

